| Validation of the NCCN‐IPI for diffuse large B‐cell lymphoma (DLBCL): the addition of β2‐microglobulin yields a more accurate GELTAMO‐IPI C Montalbán, A Díaz‐López, I Dlouhy, J Rovira, A Lopez‐Guillermo, ... British Journal of Haematology 176 (6), 918-928, 2017 | 103 | 2017 |
| Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma M Kwon, G Iacoboni, JL Reguera, LL Corral, RH Morales, ... Haematologica 108 (1), 110, 2022 | 101 | 2022 |
| Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma G Iacoboni, K Rejeski, G Villacampa, JA van Doesum, A Chiappella, ... Blood advances 6 (12), 3606-3610, 2022 | 84 | 2022 |
| Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation M Bastos‐Oreiro, A Perez‐Corral, C Martínez‐Laperche, L Bento, ... European Journal of Haematology 93 (3), 239-246, 2014 | 83 | 2014 |
| Recent bendamustine treatment before apheresis has a negative impact on outcomes in patients with large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy G Iacoboni, V Navarro, AÁ Martín-López, K Rejeski, M Kwon, KA Jalowiec, ... Journal of Clinical Oncology 42 (2), 205-217, 2024 | 77 | 2024 |
| Risk factors and mortality of COVID-19 in patients with lymphoma: a multicenter study I Regalado-Artamendi, A Jiménez-Ubieto, JÁ Hernández-Rivas, ... Hemasphere 5 (3), e538, 2021 | 72 | 2021 |
| New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta‐2 microglobulin in patients with diffuse large B‐cell lymphoma … L Bento, A Díaz‐López, G Barranco, AM Martín‐Moreno, M Baile, A Martín, ... British journal of haematology 188 (6), 888-897, 2020 | 65 | 2020 |
| Best treatment option for patients with refractory aggressive B-cell lymphoma in the CAR-T cell era: real-world evidence from GELTAMO/GETH Spanish groups M Bastos-Oreiro, A Gutierrez, JL Reguera, G Iacoboni, L López-Corral, ... Frontiers in immunology 13, 855730, 2022 | 38 | 2022 |
| Next-generation sequencing improves diagnosis, prognosis and clinical management of myeloid neoplasms D Carbonell, J Suárez-González, M Chicano, C Andrés-Zayas, JC Triviño, ... Cancers 11 (9), 1364, 2019 | 34 | 2019 |
| Genetic analyses of aplastic anemia and idiopathic pulmonary fibrosis patients with short telomeres, possible implication of DNA-repair genes EG Arias-Salgado, E Galvez, L Planas-Cerezales, L Pintado-Berninches, ... Orphanet journal of rare diseases 14, 1-12, 2019 | 32 | 2019 |
| Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel RM Martín‐Rojas, I Gómez‐Centurión, R Bailén, M Bastos, ... Clinical Case Reports 10 (1), e05209, 2022 | 30 | 2022 |
| RELINF: prospective epidemiological registry of lymphoid neoplasms in Spain. A project from the GELTAMO group M Bastos-Oreiro, A Muntanola, C Panizo, E Gonzalez-Barca, ... Annals of Hematology 99, 799-808, 2020 | 30 | 2020 |
| CD3+ graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide A Mussetti, C De Philippis, C Carniti, M Bastos-Oreiro, J Gayoso, N Cieri, ... Bone Marrow Transplantation 53 (12), 1522-1531, 2018 | 27 | 2018 |
| Inhibitory killer cell immunoglobulin‐like receptor (iKIR) mismatches improve survival after T‐cell‐repleted haploidentical transplantation M Bastos‐Oreiro, J Anguita, C Martínez‐Laperche, L Fernández, E Buces, ... European journal of haematology 96 (5), 483-491, 2016 | 27 | 2016 |
| R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients≥ 60 years: results of a randomized phase 2 study from the Spanish GELTAMO group JM Sancho, R Fernández‐Alvarez, F Gual‐Capllonch, E González‐García, ... Cancer Medicine 10 (4), 1314-1326, 2021 | 25 | 2021 |
| Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study L Bento, A Gutiérrez, S Novelli, J Montoro, JL Piñana, L López-Corral, ... Bone Marrow Transplantation 56 (8), 1919-1928, 2021 | 20 | 2021 |
| Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study AM García-Sancho, M Bellei, M López-Parra, G Gritti, M Cortés, S Novelli, ... Haematologica 107 (11), 2675, 2022 | 19 | 2022 |
| EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment C Martínez-Laperche, L Sanz-Villanueva, FJ Díaz Crespo, P Muñiz, ... BMC cancer 22 (1), 982, 2022 | 18 | 2022 |
| Mosunetuzumab and polatuzumab vedotin demonstrates preliminary efficacy in elderly unfit/frail patients with previously untreated diffuse large B-cell lymphoma AJ Olszewski, H Eradat, A Avigdor, NA Horowitz, S Babu, I Levi, ... Blood 142, 855, 2023 | 17 | 2023 |
| Incorporating genetic and clinical data into the prediction of thromboembolism risk in patients with lymphoma M Bastos‐Oreiro, J Ortiz, V Pradillo, E Salas, C Marínez‐Laperche, ... Cancer Medicine 10 (21), 7585-7592, 2021 | 17 | 2021 |